Bristol Myers Squibb vs Danaher (BMY vs DHR)

Bristol Myers Squibb (BMY) vs Danaher (DHR) in plain English: P/E, growth, margins, debt and dividend side by side, key differences and which fits each investor profile.

Bristol Myers Squibb (BMY) and Danaher (DHR) compete in healthcare and pharma. Here are Bristol Myers Squibb and Danaher side by side with their real figures as of November 4, 2026: what sets them apart, which fits each kind of investor and the most common questions, without telling you whether to buy Bristol Myers Squibb or Danaher.

Bristol Myers Squibb vs Danaher: the figures

Bristol Myers Squibb and Danaher figures from Yahoo Finance, the same source the Fintols analysis uses, retrieved on November 4, 2026; N/A means that Bristol Myers Squibb or Danaher figure is not available, and we never estimate it.

3 key differences between Bristol Myers Squibb and Danaher

1. Valuation: Danaher trades at 38.9x its annual earnings and Bristol Myers Squibb at 14.2x; the market pays more for each dollar of Danaher profit, usually because it expects more growth.
2. Dividend: Bristol Myers Squibb yields 4.08% at today's price and Danaher yields 0.70%.
3. Volatility: Danaher stock moves more (beta 0.80) than Bristol Myers Squibb (beta 0.19); the higher the beta, the more it amplifies market swings.

Bristol Myers Squibb or Danaher: which fits your profile

• If you want growth: Danaher is growing faster today, so it fits better with investors who put business growth first, usually accepting a higher P/E and a bumpier ride.
• If you want income (dividends): Bristol Myers Squibb pays the higher dividend relative to its price.
• If you prefer caution: Bristol Myers Squibb has less debt relative to its profit, which usually gives more room in a bad year.
• If price is what matters most to you: Bristol Myers Squibb trades on the lower P/E; check first whether that is an opportunity or a sign of a business that grows less.

Neither Bristol Myers Squibb nor Danaher wins on everything, and owning both is also an option: spreading money across several companies or an index fund reduces what rides on each one.

How Bristol Myers Squibb and Danaher make money

Bristol Myers Squibb (BMY)

Bristol Myers Squibb sells prescription drugs in a single segment. Its biggest products are Eliquis, a blood thinner marketed with Pfizer, and Opdivo, a cancer immunotherapy, along with Revlimid, Pomalyst, Breyanzi, Camzyos and the schizophrenia drug Cobenfy. The United States generates most of its revenue. Full Bristol Myers Squibb analysis.

Danaher (DHR)

Danaher sells instruments, reagents and consumables to labs, hospitals and drugmakers. Diagnostics, its largest segment, includes Beckman Coulter Diagnostics, Cepheid, Radiometer and Leica Biosystems. Biotechnology, built around Cytiva, supplies tools for making biologic drugs, and Life Sciences includes SCIEX, Leica Microsystems and IDT. Full Danaher analysis.

Frequently asked questions: Bristol Myers Squibb vs Danaher

Is Bristol Myers Squibb or Danaher the better stock?

Choosing between Bristol Myers Squibb and Danaher depends on what you are looking for. Danaher is growing faster right now, and Bristol Myers Squibb trades on the lower P/E. Fintols does not tell you whether to buy Bristol Myers Squibb or Danaher: it shows you the differences so you can decide.

Which pays a higher dividend, Bristol Myers Squibb or Danaher?

As of November 4, 2026, Bristol Myers Squibb yields 4.08% and Danaher yields 0.70%. Also check how much of their profit Bristol Myers Squibb and Danaher pay out: if it is more than they earn, it cannot last.

Which is more expensive, Bristol Myers Squibb or Danaher?

On P/E, Danaher (38.9x) is more expensive than Bristol Myers Squibb (14.2x) as of November 4, 2026. A higher P/E can be justified if earnings grow faster, so compare it with each company's growth in the table.

Can I own both Bristol Myers Squibb and Danaher?

Yes. Many people spread their money across several companies, such as Bristol Myers Squibb and Danaher, or use index funds so they do not depend on just one. If you are starting out, decide how much you want to invest and for how long before buying Bristol Myers Squibb or Danaher.

More comparisons with Bristol Myers Squibb or Danaher

• Bristol Myers Squibb vs CVS Health
• Bristol Myers Squibb vs Gilead
• Bristol Myers Squibb vs Eli Lilly
• CVS Health vs Danaher

More companies like Bristol Myers Squibb and Danaher: healthcare and pharma stocks. Educational content about Bristol Myers Squibb and Danaher, not investment advice.